Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy
- Conditions
- Kidney Tumor
- Registration Number
- NCT06056505
- Lead Sponsor
- University of Leipzig
- Brief Summary
The primary objective is to determine if 3D modelling shortens total console operation time as a surrogate endpoint for clinical outcomes like perioperative complications and morbidity in robotic-assisted partial nephrectomy.
- Detailed Description
3DPN is a prospective, multicentre, randomised, controlled, two-armed, open trial to compare the 3D modelling with the 2D modelling in robotic-assisted partial nephrectomy. According to the randomisation the 3D or 2D modelling is used for patient information (before intervention) and for partial nephrectomy. A six-month follow-up visit is provided.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 370
- Patients with kidney tumours ≤ 7cm and planned robotic-assisted partial nephrectomy with the DaVinci Surgical System
- CT scan with contrast medium available
- Age ≥ 18 years
- Written informed consent
- History of surgery on affected kidney (e.g., partial nephrectomy, pyeloplasty, kidney cyst deroofing, percutaneous nephrolitholapaxy, radiofrequency ablation)
- Horseshoe kidney
- Previous malignancy with ongoing or planned nephrotoxic chemotherapy
- Patient is immunosuppressed (e.g., organ transplantation, leukaemia)
- Tumor thrombus in Vena renalis or Vena cava inferior
- Existing renal insufficiency GFR < 15 ml/min/1.73m2
- Severe cognitive impairment
- Pregnancy or lactation or women with desire for children
- Patients under legal supervision or guardianship
- Unable to give informed consent or suspected lack of compliance
- Patients who refuse to data collection and storage for the main study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Primary endpoint is the console operation time measured intra-op. intra-operative Total console time is measured as time from starting the surgical procedure in the DaVinci console to ending the procedure in the console.
- Secondary Outcome Measures
Name Time Method Pre-operative - APAIS Visit 1: pre-operative (between surgery consent and operation - latest 7 days after surgery consent) Amsterdam Preoperative Anxiety and Information Scale (APAIS) for anxiety; six items with five expressions from "Do not agree at all" to "strongly agree"
Peri-operative - Number of transfusions Visit 2: during operation Number of transfusions
Post-operative - Creatinine from the end of operation until discharge (up to 6 days) and at Visit 4: 6 month after operation Creatinine in µmol/l
Pre-operative - STOA Visit 1: pre-operative (between surgery consent and operation - latest 7 days after surgery consent) STATE-TRAIT-Operations-Angst (STOA) for anxiety; thirty items with four expressions from "not at all" to "very"
Pre-operative - NRS Visit 1: pre-operative (between surgery consent and operation - latest 7 days after surgery consent) numeric rating scale (NRS) for anxiety; numeric scale form one to ten (not afraid at all to very big anxiety)
Pre-operative - Patient satisfaction questionnaire Visit 1: pre-operative (between surgery consent and operation - latest 7 days after surgery consent) Patient satisfaction questionnaire regarding the informed consent process
Peri-operative - Hilar clamping technique Visit 2: during operation Hilar clamping technique (three levels: global ischemia, selective ischemia, clampless)
Peri-operative - Number of conversions to open surgery Visit 2: during operation Number of conversions to open surgery
Peri-operative - Number of conversions to radical nephrectomy Visit 2: during operation Number of conversions to radical nephrectomy
Peri-operative - Total Operative time Visit 2: during operation Total Operative time measured from incision to suture in minutes
Pre-operative - PRA-D Visit 1: pre-operative (between surgery consent and operation - latest 7 days after surgery consent) Quality of the Physician-Patient Relationship - Evaluation of the German Version of the Patient Reactions Assessment (PRA-D); fifteen items with seven expressions from "I do not agree at all" to "I agree completely"
Peri-operative - Estimated blood loss Visit 2: during operation Estimated blood loss in ml
Post-operative - Positive margin status Visit 3: after operation up to 6 weeks Positive margin status, range: R0, R1, R2, RX
Peri-operative - Surgeon confidence level Visit 2: during operation Surgeon confidence level evaluated by questionnaire survey; five questions with five expressions from "excellent" to "very bad"
Post-operative - eGFR from the end of operation until discharge (up to 6 days) and at Visit 4: 6 month after operation eGFR (CKD-EPI) in ml/min/1,73m²
Peri-operative - Warm ischaemia time (WIT) Visit 2: during operation Warm ischaemia time (WIT) in minutes
Post-operative - Patient length of stay from day of hospitalization (up to 7 days before operation) until the day of discharge (up to 6 days) Patient length of stay in days
Trial Locations
- Locations (8)
Universitätsklinikum Carl Gustav Carus Dresden, Klinik und Poliklinik für Urologie
🇩🇪Dresden, Saxonia, Germany
Leipzig University, Department of Urology
🇩🇪Leipzig, Saxonia, Germany
Sana Klinikum Borna, Klinik für Urologie
🇩🇪Borna, Germany
St. Antonius-Hospital Gronau, Klinik für Urologie, Kinderurologie und Urologische Onkologie
🇩🇪Gronau, Germany
Universitätsklinikum des Saarlandes - Homburg/Saar, Klinik für Urologie und Kinderurologie
🇩🇪Homburg, Germany
Universitätsklinikum Magdeburg, Klinik für Urologie, Uroonkologie, robotergestützte und fokale Therapie
🇩🇪Magdeburg, Germany
Universitätsmedizin Mainz, Klinik und Poliklinik für Urologie und Kinderurologie
🇩🇪Mainz, Germany
Universitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie
🇩🇪Mannheim, Germany
Universitätsklinikum Carl Gustav Carus Dresden, Klinik und Poliklinik für Urologie🇩🇪Dresden, Saxonia, GermanyChristian Thomas, Prof.ContactChristian.Thomas@ukdd.de